Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Amoxicilina/Ácido clavulánico NORMON 1.000 mg/200 mg polvo para solución inyectable y para perfusión EFG, Amoxicilina/Ácido clavulánico NORMON 875 mg/125 mg comprimidos recubiertos con película EFG
The George Institute
Complicated acute appendicitis
1 trial -
Aripiprazole
Otsuka Beijing Research Institute
Schizophrenia
3 trials -
BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted), Spikevax bivalent Original/Omicron BA.1 25 micrograms/25 micrograms dispersion for injection COVID 19 mRNA Vaccine, Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Comirnaty JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Nuvaxovid dispersion for injection COVI
The George Institute
COVID-19 infection
1 trial -
BUDESONIDE
The George Institute
Chronic obstructive pulmonary disease (COPD)
1 trial -
Betadine bucal 100 mg/ml solución bucal, Agua oxigenada Foret 3 % solución cutánea y concentrado para solución bucal, Agua para preparaciones inyectables Meinsol, disolvente para uso parenteral
The George Institute
Respiratory diseases
1 trial -
CARDIOPLEGIA SOLUTIONS
The George Institute
Cardiovascular pathology
1 trial -
CARVEDILOL, CARVEDILOL, FLECAINIDE
The George Institute
Idiopathic ventricular arrhythmias
1 trial -
CEFEPIME, TEICOPLANIN, METRONIDAZOLE, METRONIDAZOLE, MEROPENEM, TAZOBACTAM, VANCOMYCIN, LEVOFLOXACIN, CIPROFLOXACIN, CEFTAZIDIME, METRONIDAZOLE, CIPROFLOXACIN, LEVOFLOXACIN, AMIKACIN, CIPROFLOXACIN, PIPERACILLIN
The George Institute
Infectious diseases
1 trial -
CEFIXIME, CIPROFLOXACIN HYDROCHLORIDE, FOSFOMYCIN
The George Institute
Acute bacterial prostatitis
1 trial -
CELLULOSE, MICROCRYSTALLINE, COLLOIDAL SILICON DIOXIDE, CROSCARMELLOSE SODIUM, MAGNESIUM STEARATE, DARIDOREXANT
The George Institute
Patients with major depressive episode and moderate to severe insomnia disorder
1 trial -
CHORIOGONADOTROPIN ALFA , ESTRADIOL , PROGESTERONE
The George Institute
Infertility
1 trial -
CIPROFLOXACIN, CIPROFLOXACIN , CEFTRIAXONE , CEFTRIAXONE
The George Institute
Graft pyelonephritis in kidney transplant recipients
1 trial -
Cilostazol
Otsuka Beijing Research Institute
Cerebral Infarction
1 trial -
Cilostazol
Otsuka Beijing Research Institute
Polyneuropathy
1 trial -
Clensia polvo para solución oral., CitraFleet Polvo para solución oral en sobre
The George Institute
colorectal cancer early detection
1 trial -
Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 0.2 mg/mL dispersion for injection COVID-19 mRNA Vaccine, EVUSHELD 150 mg + 150 mg solution for injection, Xevudy 500 mg concentrate for solution for infusion, Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)
The George Institute
Covid-19 infection
1 trial -
Cyclogest 400 mg óvulos
The George Institute
Infertility
1 trial -
DABIGATRAN ETEXILATE , CLOPIDOGREL , RIVAROXABAN , APIXABAN , ACENOCOUMAROL , EDOXABAN
The George Institute
patients who are requested a colonoscopy for any indication and are under antiplatelet treatment (except ASA) or anticoagulant treatment
1 trial -
DARBEPOETIN ALFA
The George Institute
hepatic trasplant
1 trial -
DOBUTAMINE , LEVOSIMENDAN
The George Institute
Heart failure patients with depressed left ventricular ejection fraction
1 trial -
Denominación Común Internacional (DCI): placebo (Suero fisiológico) Denominación Química: Cloruro Sódico 0.9% Forma molecular: NaCl Composición cuali y cuantitativa: 9mg/ml Forma farmacéutica: solución para pulverización nasal Dosis y vía de administración: 0.6ml/ día (6 pulverizaciones ) vía intranasa, Syntocinon 40 U.I./ml Solução para pulverização nasal
The George Institute
Borderline Personality Disorder.
1 trial -
Doxorubicin Accord 2 mg/ml koncentrat till infusionsvätska, lösning, Paclitaxel Accord 6 mg/ml koncentrat till infusionsvätska, lösning, Docetaxel Ebewe 10 mg/ml koncentrat till infusionsvätska, lösning, Epirubicin Accord 2 mg/ml injektions-/infusionsvätska, lösning, Sendoxan pulver till injektionsvätska, lösning
The George Institute
Breast cancer female NOS
1 trial -
ENDORET-PRGF
The George Institute
pterygium
1 trial -
ESTRIOL , ESTRADIOL HEMIHYDRATE, PROMESTRIENE, PROGESTERONE, ESTRADIOL VALERATE
The George Institute
Cervical cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources